Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other biologically active molecules. Its structure supports the construction of nitrogen-containing heterocycles, which are common in drug design. The tert-butyl carbamate (Boc) protecting group allows for controlled amine reactivity during multi-step syntheses, making it valuable in solid-phase and solution-phase peptide-like assembly processes. Commonly employed in medicinal chemistry for optimizing lead compounds in treatments targeting inflammatory diseases, cancer, and central nervous system disorders.